310 related articles for article (PubMed ID: 21060333)
1. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.
Ben-Zvi I; Livneh A
Nat Rev Rheumatol; 2011 Feb; 7(2):105-12. PubMed ID: 21060333
[TBL] [Abstract][Full Text] [Related]
2. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
Çakan M; Karadağ ŞG; Tanatar A; Sönmez HE; Ayaz NA
J Clin Rheumatol; 2021 Jan; 27(1):1-4. PubMed ID: 31524848
[TBL] [Abstract][Full Text] [Related]
3. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever.
Başar O; Oztürk MA; Köklü S; Ayaz S; Yüksel O; Kiraz S; Ertenli I; Calgüneri M
Joint Bone Spine; 2007 Jan; 74(1):52-5. PubMed ID: 17223601
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma levels in familial Mediterranean fever.
Köklü S; Oztürk MA; Balci M; Yüksel O; Ertenli I; Kiraz S
Joint Bone Spine; 2005 Jan; 72(1):38-40. PubMed ID: 15681246
[TBL] [Abstract][Full Text] [Related]
6. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy.
Bonfrate L; Scaccianoce G; Palasciano G; Ben-Chetrit E; Portincasa P
Eur J Clin Invest; 2017 Sep; 47(9):622-629. PubMed ID: 28678379
[TBL] [Abstract][Full Text] [Related]
7. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
8. [Familial Mediterranean fever].
Leclercq P; Hermesse A; Malaise MG
Rev Med Liege; 2004 May; 59(5):320-5. PubMed ID: 15264584
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
Calligaris L; Marchetti F; Tommasini A; Ventura A
Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
[TBL] [Abstract][Full Text] [Related]
10. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?
Can Sandikci S; Omma A; Yucel C; Omma T
Clin Rheumatol; 2021 Feb; 40(2):669-674. PubMed ID: 32623649
[TBL] [Abstract][Full Text] [Related]
11. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder?
Aldea A; Campistol JM; Arostegui JI; Rius J; Maso M; Vives J; Yagüe J
Am J Med Genet A; 2004 Jan; 124A(1):67-73. PubMed ID: 14679589
[TBL] [Abstract][Full Text] [Related]
12. Familial mediterranean fever in Arabs.
El-Shanti H; Majeed HA; El-Khateeb M
Lancet; 2006 Mar; 367(9515):1016-24. PubMed ID: 16564365
[TBL] [Abstract][Full Text] [Related]
13. Plasma and platelet serotonin levels in familial Mediterranean fever.
Onat AM; Ozçakar L; Oztürk MA; Uçar G; Ureten K; Dagli N; Kiraz S; Ertenli I; Calgüneri M
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S16-20. PubMed ID: 17949546
[TBL] [Abstract][Full Text] [Related]
14. Colchicine modulates oxidative stress in serum and leucocytes from remission patients with Family Mediterranean Fever through regulation of Ca²+ release and the antioxidant system.
Sahin M; Uğuz AC; Demirkan H; Nazıroğlu M
J Membr Biol; 2011 Mar; 240(1):55-62. PubMed ID: 21249347
[TBL] [Abstract][Full Text] [Related]
15. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for subclinical inflammation in children with Familial Mediterranean fever.
Bayram MT; Çankaya T; Bora E; Kavukçu S; Ülgenalp A; Soylu A; Türkmen M
Rheumatol Int; 2015 Aug; 35(8):1393-8. PubMed ID: 25669438
[TBL] [Abstract][Full Text] [Related]
17. [Familial Mediterranean fever].
Steiss JO; Wiemann J; Rutz A; Wössmann W; Gortner L
Klin Padiatr; 2001; 213(2):86-8. PubMed ID: 11305198
[TBL] [Abstract][Full Text] [Related]
18. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.
Berkun Y; Padeh S; Reichman B; Zaks N; Rabinovich E; Lidar M; Shainberg B; Livneh A
Semin Arthritis Rheum; 2007 Dec; 37(3):182-8. PubMed ID: 17512038
[TBL] [Abstract][Full Text] [Related]
19. QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.
Nussinovitch U; Kaminer K; Nussinovitch M; Volovitz B; Lidar M; Nussinovitch N; Livneh A
Clin Rheumatol; 2012 May; 31(5):795-9. PubMed ID: 22271228
[TBL] [Abstract][Full Text] [Related]
20. Cardiac disease in familial Mediterranean fever.
Erken E; Erken E
Rheumatol Int; 2018 Jan; 38(1):51-58. PubMed ID: 29051974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
